XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 200 | $372 | 0.00% |
OSAIC HOLDINGS, INC. | 22,034 | $40,983 | 0.00% |
FMR LLC | 9,292 | $17,282 | 0.00% |
Parallel Advisors, LLC | 3,294 | $6,127 | 0.00% |
BANK OF AMERICA CORP /DE/ | 69,787 | $129,803 | 0.00% |
Russell Investments Group, Ltd. | 119 | $221 | 0.00% |
WELLS FARGO & COMPANY/MN | 36,989 | $68,800 | 0.00% |
NORTHERN TRUST CORP | 1,145,217 | $2,130,104 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 55,742 | $103,680 | 0.00% |
GROUP ONE TRADING, L.P. | 66,170 | $123,076 | 0.00% |
Legal & General Group Plc | 15,335 | $28,523 | 0.00% |
ROYAL BANK OF CANADA | 22,797 | $43,000 | 0.00% |
STATE STREET CORP | 2,570,122 | $4,780,427 | 0.00% |
SG Americas Securities, LLC | 18,363 | $34 | 0.00% |
This page lists XERIS BIOPHARMA HOLDINGS INC's shareholders in Q3 2023. To view XERIS BIOPHARMA HOLDINGS INC's shareholder history, click here.